Tuesday, May 16, 2017 8:00:33 PM
Dear Hydropothecary Investor,
This morning Hydropothecary announced the precautionary voluntary stop sale implemented on May 2, 2017 has been lifted. We currently have 13 of 14 products available for sale. Clients can order their products as normal, through the online store or by calling our 24/7 line at 1-844-406-1852.
Additionally, Hydropothecary initiated a precautionary voluntary recall of fourteen lots of medical marijuana. This is the result of the presence of myclobutanil, a pesticide approved for use in agriculture (e.g. apples trees, almonds, strawberries, vegetables, soybeans and grape vines) but is not approved for use on cannabis. These lots have tested positive for traces amounts over 0.01 parts per million (ppm), but no more than 0.08 ppm.
Health Canada has deemed this a Type III recall, defined as "a situation in which the use of, or exposure to a product is not likely to cause any adverse health consequences." All affected clients are being notified.
Press Release: http://mwne.ws/2qngfM0
As part of our commitment to transparency to our clients, our investors and the public, we will continue to provide regular updates, on our website: http://thehydropothecary.com/daily-updates
Recent HEXO News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/03/2023 08:15:19 PM
- HEXO Corp. Announces Completion of Acquisition by Way of Arrangement With Tilray Brands, Inc. • Business Wire • 06/22/2023 09:02:00 PM
- Tilray Brands Completes Accretive Acquisition of HEXO Corp. Leading the Next Evolution of Canadian Cannabis • GlobeNewswire Inc. • 06/22/2023 09:00:00 PM
- HEXO Corp. Announces Receipt of Final Order for Arrangement With Tilray Brands, Inc. • Business Wire • 06/19/2023 08:06:00 PM
- HEXO Reports Q3’23 Financial Results • Business Wire • 06/14/2023 08:51:00 PM
- Hexo Corp.’s Shareholders Approve Acquisition by Way of Arrangement With Tilray Brands, Inc. • Business Wire • 06/14/2023 04:17:00 PM
- HEXO to Host Third Quarter 2023 Earnings Conference Call • Business Wire • 06/12/2023 09:10:00 PM
- HEXO Announces Closing of Non-Brokered Private Placement and Amendments to Arrangement Agreement and Waiver and Amendment Agreement • Business Wire • 06/01/2023 09:30:00 PM
- Leading Independent Proxy Advisory Firm ISS Recommends HEXO Shareholders Vote FOR the Arrangement Agreement with Tilray Brands • Business Wire • 05/26/2023 11:00:00 AM
- HEXO Corp. Files Circular for Special Meeting of Shareholders to Approve Arrangement With Tilray Brands, Inc. • Business Wire • 05/16/2023 11:00:00 AM
- HEXO Corp. Announces Receipt of Interim Order in Respect of Arrangement With Tilray Brands, Inc. • Business Wire • 05/10/2023 08:45:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM